FAQs



Can’t find what you are looking for? Get in touch and we’ll get back to you as soon as we can

Contact Us

The FDA reviewed both device performance data and the new Eversense Mobile App, and determined that Eversense is safe for making diabetes treatment decisions without a confirmatory fingerstick (also known as “non-adjunctive use”). Treatment decisions include determining a patient’s insulin dose and whether or not they should consume carbohydrates. Always consult with your Health Care Provider prior to making changes to treatment, diet or exercise.

No, fingersticks are still required in the following situations:

  • For daily calibrations (2 times/day).
  • When symptoms do not match the glucose reading displayed on the Eversense Mobile App.
  • If the Eversense Mobile App does not show both a number and a trend arrow.
  • If users are taking medications of the tetracycline class.

Disclaimer

The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a Health Care Provider. The Eversense CGM System is a prescription device; patients should talk to their Health Care Provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.

Eversense, Eversense Continuous Glucose Monitoring, Eversense CGM, Eversense Sensor, Eversense Smart Transmitter, Eversense App and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Other brands and their products are trademarks or registered trademarks of their respective holders.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System.
Android is a trademark of Google LLC.

© 2021 Senseonics, Incorporated. All rights reserved.
© 2021 Ascensia Diabetes Care Holdings AG. All rights reserved.